Repurposing of Sitagliptin- Melittin Optimized Nanoformula against SARS-CoV-2: Antiviral Screening and Molecular Docking Studies

Repurposing of Sitagliptin- Melittin Optimized Nanoformula against SARS-CoV-2: Antiviral Screening and Molecular Docking Studies

The outbreak of the COVID-19 pandemic in China has become an urgent health and economic challenge. The objective of the current work was to evaluate the efficacy of the combined complex of Sitagliptin (SIT) with melittin (MEL) against SARS-CoV-2 virus. SIT-MEL nano-conjugates were optimized by a ful...

Full description

Bibliographic Details
Main Authors: Mohammed W. Al-Rabia, Nabil A. Alhakamy, Osama A. A. Ahmed, Khalid Eljaaly, Ahmed L. Aloafi, Ahmed Mostafa, Hani Z. Asfour, Ahmed A. Aldarmahi, Khaled M. Darwish, Tarek S. Ibrahim, Usama A. Fahmy
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Pharmaceutics
Subjects:
bee venom
nanoparticles
COVID-19
pandemic diseases
Online Access:https://www.mdpi.com/1999-4923/13/3/307

Internet

https://www.mdpi.com/1999-4923/13/3/307

Similar Items